MALVERN, PA — Rajant Health Incorporated (RHI) and Incite Health have announced a strategic partnership aimed at advancing precision medicine and healthcare solutions through cutting-edge technology. The collaboration seeks to improve healthcare access and equity while setting new standards for innovation in the industry.
The partnership combines the expertise of Incite Health in multiparameter biomarker diagnostic testing with RHI’s capabilities in remote health data acquisition using wearables and environmental sensors. These data inputs will be further analyzed through Trovomics’ advanced analytics to unlock insights into preventative and curative diagnostics and monitoring.
“This partnership is the next step forward in achieving my vision of the Angelverse, with Incite Health bringing new solutions to their customers, and improving lives,” said Bob Schena, CEO of RHI.
The joint effort is expected to provide significant advancements in healthcare delivery and management, particularly for underserved populations. By combining resources, RHI and Incite Health aim to secure government funding to promote innovative healthcare solutions for both civilian and military communities.
“Our combined resources will support access to government funding to promote the development of pioneering solutions that reshape how healthcare is delivered and managed,” said Renold Capocasale, CEO of Incite Health.
The collaboration underscores a shared commitment to enhancing the standard of care through technology-driven solutions, with a focus on equity and accessibility. Both companies are confident their partnership will mark a major milestone in advancing biomarker analysis services and healthcare insights, ultimately improving patient outcomes across diverse populations.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.